C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A01N 43/04 (2006.01) A61K 48/00 (2006.01) C12N 5/10 (2006.01) C12N 7/00 (2006.01) C12N 15/38 (2006.01) C12N 15/869 (2006.01) C12N 15/90 (2006.01) C12N 5/08 (2006.01)
Patent
CA 2354844
The use of a unique terminal repeat sequence derived from Epstein-Barr virus to improve the integration frequency of heterologous expression vectors in transfected cells is described. The vectors can be used in a process for deriving high producing cell lines.
La présente invention concerne l'utilisation d'un segment terminal à répétition unique dérivé du virus d'Epstein-Barr, de façon à améliorer la fréquence d'intégration de vecteurs d'expression hétérogènes dans des cellules transfectées. On peut utiliser le vecteur dans un processus destiné à obtenir des lignés de cellules sécrétant un haut niveau de protéines.
Chan Sham Yuen
Cho Myung-Sam
Borden Ladner Gervais Llp
Corporation Bayer
LandOfFree
Vectors having terminal repeat sequence of epstein-barr virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors having terminal repeat sequence of epstein-barr virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors having terminal repeat sequence of epstein-barr virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1432073